LINC00092 interacted with a glycolytic enzyme named 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (PFKFB2) to modulate glycolysis levels and supportive function of CAFs, thereby facilitating ovarian cancer metastasis (201). Here, PFKFB2 is linked to ovarian cancer.